CytoDyn CYDY
OTC CYDY
$0.23 -0.01 (-4.17%)
At close: Nov 10, 2026 · 4:00 PM EST

CytoDyn (CYDY) EBITDA Margin (2018 - 2022)

Updated

CytoDyn (CYDY) recorded EBITDA Margin of -230435.29% in fiscal Q4 2022 (quarter ended May 31, 2022).

Analysis

CytoDyn (CYDY) EBITDA Margin (2018 - 2022) Analysis & Trends

For FY2022 (ended May 31, 2022), CytoDyn reported EBITDA Margin of -47221.67%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 32.68%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 46.88%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 40.60%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 39.77%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 46.62%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 50.63%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 42.49%
10 CytoDyn 334.50 Mn 285.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2022 -230,435.29%
Nov 30, 2021 -10,789.78%
Aug 31, 2021 -49,778.05%
Nov 30, 2019 -2,022.83%
Aug 31, 2019 -1,798.77%
Nov 30, 2018 -10,778.69%
Aug 31, 2018 -12,745.05%
API Access

CytoDyn EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CYDY&period=max&api_key=YOUR_API_KEY